tibia 1:301, 330, 341; 4: 231
tic 1: 75 , 286,287, 320
tick bites 2:311, 322, 324, 335,
336, 341, 342, 350
tinea 1: 179 , 204, 204 t
tinea versicolor 1:204–205
tinnitus 1:29, 34, 42t,43, 47, 58;
4: 261
tissue expansion 1: 163 , 205
TMP-SMZ. Seetrimethoprim-
sulfamethoxazole
TNM system 2:392–393, 393t
tobacco 4:8, 14, 314, 345, 353. See
alsosmoking
tobacco use other than smoking
4:306–307, 307 t. See also
smokeless tobacco
toenails 1:129, 167
toes 1:145–146, 350, 357
tolerance 4:353–354
tolterodine (Detrol) 3:188, 224,
225
tongue 1:25, 26, 57
tonometry 1:93, 97, 104, 119
tonsillitis 1: 6 , 58–59
tonsils 1:44, 57–59
toothache 1: 20 , 57
topiramate 3:367, 377
torsade de pointes 2:74, 82, 111
torticollis 1:360
totipotent cells 4:115, 140
Tourette’s syndrome 1:287
toxic epidermal necrolysis 1:205
toxic megacolon 3: 58 , 93
toxic optic neuropathy 1:119–120,
119 t
toxic shock syndrome 1:47; 2:357
Toxoplasma gondii2:357, 358
toxoplasmosis 1:238; 2: 322 ,
357–358
trace minerals 4:184, 186, 187
trachea 1:5, 182; 2:233–234
alveolus 2: 183
auscultation 2: 191
breathing 2: 193
breath sounds 2: 194
bronchoscopy 2: 197
bronchus 2: 197
drowning 4: 368
inhalation burns 4: 365
lungs 2: 212
oxygen therapy 2: 217
pleura 2: 218
positive airway pressure 2: 223
tracheostomy 2:234
tracheostomy 2: 217 , 234
traditional Chinese medicine (TCM)
3:1; 4:101–103
drugs 4: 145
ginger 4: 70
ginseng 4: 72
integrative medicine 4: 78
labyrinth 4: 79
medicinal herbs and botanicals
4: 84
naturopathy 4: 92
Sun’s Soup 4: 100
tai chi 4: 101
training 4:233–234
transcutaneous electrical nerve
stimulation (TENS) 1: 381 ,
384–385; 4:57, 81
transdermal patch 1:366, 378;
4:169–170, 334
trans fats 4:181, 192
transforming growth factors (TGFs)
2:296–297
transient ischemic attack (TIA)
2: 22 , 111
translocation 4:118, 128, 143
transmission modes 2: 315 , 358;
4:26, 341
transmyocardial laser
revascularization (TMLR) 2: 12 ,
111–112
transplant-related Kaposi’s sarcoma
1:168, 169
transposition of the great arteries
(TGA) 2:6, 39
trauma prevention 4:48–49
traumatic amputation 4: 361 , 380
traumatic brain injury (TBI)
1:287–288; 3: 379
apraxia 1: 226
blunt trauma 4: 377
cognitive function and
dysfunction 1: 244
concussion 1:244–245
dementia 1: 251
head and spinal cord injuries
4: 378
papilledema 1: 107
paralysis 1: 275
water safety 4: 50
trauma to the eye 4:379–380
tremor disorders 1:227, 250, 252,
265–266, 274–276, 288–289
TRH. Seethyrotropin-releasing
hormone
triceps skinfold 4:307
trichomoniasis 2:358
trichotillomania 3:386, 386 ttricyclic antidepressants (TCAs)
1:268; 3:361, 378
trigeminal nerve 1:54, 246, 247t
triglyceride blood level 1:211; 2:36,
64, 65, 82, 112, 112 t
triglycerides, dietary 4: 192 ,
202–203
triiodothyronine (T 3 ) 3:99, 130,
139, 146, 162, 166
trimethoprim-sulfamethoxazole
(TMP-SMZ) 2:320, 349, 353, 360
triptans 1:374, 377
trisomy 4:117, 128
trochlear nerve 1:246, 247t
trophozoite 2:307, 329
tropia. Seestrabismus
trough level 4:168, 172, 172–173
TSE. Seetesticular self-examination
TSH. Seethyroid-stimulating
hormone
tubal ligation 3: 281 , 347–348
tuberculosis 2:229, 230, 304, 305,
359–360, 359 t;4:2, 46, 49, 340
tuberculosis prevention 4:49, 358
tubule 3:169, 171, 172
tumor, cancerous. See also
adenocarcinoma
adenoma-to-carcinoma
transition 2: 366
angiogenesis inhibitor drugs
2:368
bladder cancer 3: 179
blastoma 2:368–369
brain tumor 1:235–237
cancer 2: 364
cancer of the penis 3: 256
carcinoma 2:374–375
cervical cancer 3: 256
endometrial cancer 3: 273
lung cancer 2: 208
neurofibromatosis 1: 269
ovarian cancer 3: 309
prostate cancer 3: 327
radiation therapy 2: 388
retinoblastoma 1:114
thyroid nodules 3: 164
tumor, noncancerous (benign)
acoustic neuroma 1:7
adenocarcinoma 2: 366
adenoma 3: 107
adenoma-to-carcinoma
transition 2: 366
angioma 1:138
blastoma 2: 369
brain tumor 1:235–237
dermatofibroma 1:152Index 509